Top Hedge Fund News, Member Posts, Hedge Fund Daily Indices and more!

4yrs ago Hedge Fund dealbreaker Views: 241

At least according to these new numbers it ain't.

Imagine you figured out a way to re-package a nicotine-delivery system in a sexy, pricey box and took a nice bite out of the $35 billion tobacco industry by selling said stawberry milk-flavored pods to thousands of young people. Then imagine that Altria got on your investment train by buying 35% of your company for $12.8 billion.

You’d be rich. You’d be Juul.

You’d also be in danger for the very first time.

Despite all the numbers above, studies are now showing that — surprise, surprise — sucking in vaporized chemicals isn’t so good for you after all. After the CDC reported 18 vaping-related deaths in the United States alone, aforementioned Altria is reportedly in the process of writing down its Juul investment.

It’s not just the company’s valuation that’s changing in light of reality. Hiring and workforce data shows that, for the first time, the company is slowing its roll internally by reducing the number of open positions for which it’s hiring.

-

This graph [no, that’s not a roller coaster] shows that, after a year of steady job opening growth, Juul hit the brakes on hiring hard in August. Just two months ago, Juul was hiring for 685 people. By October 1, that number was down to 434.

“But Juul is still hiring 434 people,” you say.

The company may have that many openings still, but data via LinkedIn that tracks the number of users listing Juul as their employer shows that workforce growth at the company is indeed slowing down.

-

Last year, Juul’s QoQ workforce growth was a smokey 51%. As of this week it’s down to just 2.1%, signaling that company growth isn’t just slowing, but the company size may soon begin to… I’m gonna do it… vaporize.

There is some potential good news in the data for Altria and others who want to see Juul succeed. 


Joshua Fruhlinger is the publisher of Thinknum Media.


Today's Hedge Fund Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.